Placement of metallic biliary endoprostheses in complex hilar tumours  by Maillard, M. et al.
Diagnostic and Interventional Imaging (2012) 93,  767—774
ORIGINAL ARTICLE / Gastrointestinal imaging
Placement  of  metallic  biliary  endoprostheses  in
complex  hilar  tumours
M.  Maillarda,∗,  S.  Novellasb,  G.  Baudina, L.  Evesquec,
L.  Bellmanna,  J.  Gugenheimd,  P.  Chevalliera
a Department  of  medical  imaging,  centre  hospitalier  régional  et  universitaire  de  Nice,  hôpital
L’Archet-2, 151,  route  Saint-Antoine-de-Ginestière,  BP  3079,  06202  Nice  cedex  3,  France
b Institut  Arnault-Tzanck,  avenue  du  Docteur-Maurice-Donat,  06721  Saint-Laurent-du-Var,
France
c Hepatogastroenterology  department,  centre  hospitalier  régional  et  universitaire  de  Nice,
hôpital L’Archet-2,  151,  route  Saint-Antoine-de-Ginestière,  BP  3079,  06202  Nice  cedex  3,
France
d Digestive  surgery  department,  centre  hospitalier  régional  et  universitaire  de  Nice,  hôpital
L’Archet-2,  151,  route  Saint-Antoine-de-Ginestière,  BP  3079,  06202  Nice  cedex  3,  France
KEYWORDS
Percutaneous  biliary
drainage;
Hilar
cholangiocarcinoma;
Hilar  tumour;
Endoprosthesis;
Interventional
radiology
Abstract
Purpose:  To  assess  the  technical  success,  clinical  success  and  complications  after  1  month  of
percutaneous  biliary  drainage  with  the  placement  of  several  metallic  endoprostheses  in  complex
hilar liver  tumours.
Materials  and  methods:  This  is  a  retrospective  study,  on  a  homogenous  target  population  of  68
consecutive  patients,  who  underwent  multiple  percutaneous  biliary  drainage  for  complex  hilar
tumour (Bismuth  type  II,  III  and  IV)  between  August  1998  and  August  2010.  Patients  beneﬁting
from previous  endoscopic  drainage  were  excluded  from  the  study.  The  clinical  data,  biological
data, imaging  and  interventional  radiology  procedures  were  studied.
Results:  The  rate  of  success  of  the  technique  was  98.5%  and  the  clinical  rate  of  success  was
84% after  1  week  and  93%  after  1  month.  The  rate  of  minor  and  major  complications  was  25
and 13%  respectively.
Conclusion:  Multiple  percutaneous  biliary  drainage  in  complex  hilar  tumour  is  a  safe  and  effec-
tive ﬁrst  intention  procedure.
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E-mail address: mickael.maillard@gmail.com (M. Maillard).
2211-5684/$ — see front matter © 2012 Éditions françaises de radiologie
http://dx.doi.org/10.1016/j.diii.2012.05.014iologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.. Published by Elsevier Masson SAS. All rights reserved.
7 M.  Maillard  et  al.
c
t
y
p
g
t
v
a
b
h
A
n
p
a
s
ﬁ
[
t
d
c
I
M
T
t
o
f
v
T
l
p
a
c
i
r
T
A
i
t
g
b
C
t
e
t
t
b
b
a
s
s
w
s
N
c
p
c
Total
Bismuth type I, II , II I
and IV populat ion
N=177 patients
Exclusion of Bismuth t ype I (n=3 2) 
Bismut h type II , III
and IV
N=14 5 pat ients
Exclusion  of lesions that did not  benefit fr om an 
 endoprosthesis (n=51)* 
Bismut h type II, II I and
IV with
endoprosthesis(es)
N=94 pat ients
Exclusion  of lesions that be nefited fr om an 
endoprothesis (n= 26) 
Target po pulati on
Bismuth type II , II I and IV
with several
endoprosthes es
N=68 pat ients
Figure 1. Selection of the target population for the study. *These
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Cholangiocarcinoma  and  hepatic  metastases  are  the  main
auses  of  the  obstruction  of  the  hepatic  hilum.  These
umours  have  a  poor  prognosis  with  a  mean  survival  of  5
ears  for  cholangiocarcinomas  under  5%  [1].  Most  of  these
atients  die  less  than  one  year  after  the  diagnosis  of  cholan-
iocarcinoma  [2].  The  locoregional  tumoral  invasion  and
he  alteration  of  the  patient’s  general  state  often  pre-
ent  curative  surgical  treatment  [3,4]. Palliative  treatments
re  therefore  the  only  ones  proposed  [5].  Drainage  of  the
ile  ducts,  whether  surgical,  endoscopic  or  percutaneous,
as  become  an  indispensable  palliative  treatment  [6,7].
lthough  carried  out  for  many  years,  consensus  still  has
ot  been  reached  about  the  rules  of  biliary  drainage,  in
articular  for  complex  hilar  tumours  (Bismuth  type  II,  III
nd  IV).  Certain  teams  drain  the  maximum  dilated  biliary
ectors,  others  consider  that  draining  30%  of  the  liver  suf-
ces  to  provide  a  signiﬁcant  improvement  in  the  jaundice
8—12].  The  purpose  of  this  retrospective  study  is  to  present
he  results  of  a  series  of  extensive  percutaneous  biliary
rainages  with  the  placement  of  several  endoprostheses  in
ases  of  complex  hilar  tumours  (Bismuth  type  II,  III  and
V).
aterials and methods
his  retrospective  study  selected  all  consecutive  patients
hat  underwent  biliary  drainage  for  a  malignant  obstruction
f  the  hepatic  hilum  between  August  1998  and  August  2010
or  a  total  of  177  patients.  Patients  beneﬁting  from  pre-
ious  endoscopic  drainage  were  excluded  from  the  study.
he  indication  of  biliary  drainage  was  ﬁrst  raised  fol-
owing  multidisciplinary  consultation.  The  consent  of  all
atients  was  obtained  after  being  informed  as  to  the  ther-
peutic  procedure,  its  indications,  results  and  possible
omplications.  The  clinical  data,  biological  data,  imag-
ng  and  interventional  radiology  procedures  were  studied
etrospectively.
he population
ll  177  patients  beneﬁted  from  an  assessment  of  the
maging,  most  often  comprising  abdominal  sonography,  a
horacoabdomino-pelvic  CT  and  a  hepatic  MRI.  The  locore-
ional  assessment  was  used  to  classify  the  extension  of  the
iliary  cholangiocarcinoma  according  to  the  Bismuth  and
orlette  classiﬁcation  and  plan  the  subsequent  interven-
ional  treatment  [3].  This  classiﬁcation  was  also  used  by
xtension  for  the  secondary  invasion  of  the  hilus.  A  common
herapeutic  strategy  of  drainage  was  used  by  the  interven-
ional  radiologists  of  the  department.  Therefore,  in  case  of
iliary  drainage  of  a  hilar  tumour,  each  excluded  and  dilated
iliary  sector  had  to  be  drained  and,  if  possible,  ﬁtted  with
n  endoprosthesis  in  the  absence  of  atrophy  or  major  inva-
ion  of  the  tumour  on  a  sector  or  a  lobe  of  the  liver.  A
trict  selection  provided  a  target  population  of  68  patients
ho  beneﬁted  from  biliary  drainage  with  the  placement  of
everal  endoprostheses  for  complex  hilar  tumour  (Fig.  1).
one  of  these  patients  were  candidates  for  curative  surgi-
al  treatment  due  to  the  extension  of  the  tumour  and/or  the
erformance  status  of  the  patient.  The  different  histologi-
al  types  of  tumours,  the  ASA  score,  the  symptoms  of  the
i
a
t
eatients underwent surgery or beneﬁted from external biliary
rainage.
atients  before  the  drainage  as  well  as  the  clinical  and  bio-
ogical  monitoring  during  the  month  following  the  drainage
as  obtained  in  the  68  patients.
rocedures
he  drainages,  by  ﬁve  different  hospital  practitioners  during
he  period  examined,  were  all  carried  out  under  a  general
naesthetic.  The  patients  had  adapted  antibioprophylaxis
y  a  third  generation  cephalosporin  such  as  cefazolin  before
ny  procedure.  All  of  the  patients  were  treated  in  an  inter-
ention  room  after  control  of  the  haemostasis  assessment.
he  number  of  biliary  sectors  was  ﬁrst  deﬁned  according  to
he  Bismuth  classiﬁcation,  the  trophicity  of  the  dilated  bil-
ary  sectors  and  the  hepatic  tumour  invasion  from  the  data
btained  from  the  CT,  MRI  and  sonograph.
First,  a  dilated  intrahepatic  duct  was  detected  under
onography  control  in  order  to  be  able  to  puncture  it  with  a
hin  needle  such  as  a Chiba  15  cm  long,  21  or  22  G  (gauges).
 percutaneous  transhepatic  cholangiography  was  then  car-
ied  out  in  order  to  allow  for  the  precise  analysis  of  the
natomy  of  the  biliary  tree  and  an  exact  classiﬁcation  of
he  hilar  tumour  [13]. The  cholangiography  conﬁrmed  the
lanning  of  the  drainage  procedure  by  choosing  the  biliary
ectors  to  ﬁt.
Then,  at  the  same  time  as  the  Chiba  needle,  a  spleno-
ortography  needle  was  introduced  under  scopy  to  insert  a
ydrophilic  guide  such  as  the  Térumo  0,035F  (French)  in  the
ile  ducts  of  the  sector  approached.  Several  incisions  were
equired  in  order  to  place  the  number  of  biliary  prostheses
reviously  deﬁned.  The  operator  then  crossed  the  biliary
bstructions  with  the  7F  guide  catheter  in  all  of  the  bil-
ary  sectors  approached.  After  crossing  the  obstruction,  an
ngioplasty  balloon  dilated  the  obstruction  and  facilitated
he  placement  of  the  self-expanding  uncovered  metallic
ndoprosthesis  (Fig.  2).
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Figure 2. Biliary drainage with the placement of two endoprostheses for a Bismuth type II hilar cholangiocarcinoma: a: CT at portal vein
in coronal section revealing a tissue lesion (arrow) centred on the primary biliary convergence; b and c: dilation with an angioplasty balloon
10 mm × 4 cm of obstruction at the two common bile ducts. The obstruction is detected by the impression made during the dilation (arrows);
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In  case  of  the  initial  non-crossing  of  one  of  the  obstruc-
tions,  an  external  8F  drain  was  placed  upstream  from  the
uncrossed  obstruction.  Temporary  internal/external  drains
were  placed  at  the  level  of  the  obstructions  crossed.  The
patient  was  then  seen  3  to  4  days  later  for  another  attempt
to  cross  the  obstruction  and  place  the  prosthesis.  The  ﬁnal
placement  of  the  prostheses  opposite  the  obstructions  was
controlled  at  the  end  of  the  procedure  by  cholangiography.  It
was  used  to  see  the  passage  of  the  contrast  product  at  the
duodenum  without  residual  obstruction  on  the  bile  ducts,
attesting  to  the  good  cover  of  the  obstructions.  The  place-
ment  of  the  endoprostheses  was  always  protected  by  an
internal-external  biliary  drain,  which  was  removed  on  D2
after  controlling  the  good  permeability  of  the  prostheses
(Fig.  3).
Deﬁnitions
The  success  of  the  technique  was  deﬁned  by  the  placement
of  endoprostheses  according  to  the  therapeutic  project
with  respect  to  the  obstructions  with  a  good  ﬁnal  pas-
sage  of  contrast  product  in  the  digestive  tract  during  the
ﬁnal  cholangiography.  For  this  study,  in  accordance  with
the  majority  of  publications,  we  deﬁned  clinical  success
as  a  reduction  of  30%  and  more  in  the  total  bilirubin
c
f
T
ycted obstructions. Result after opening of both prostheses.
fter  1  week  or  a  reduction  of  75%  and  more  of  the
otal  bilirubin  after  1  month,  as  measured  in  micromoles/L
14—16].  The  complications  were  divided  into  major  and
inor  complications  according  to  the  standards  of  the  Soci-
ty  of  Cardiovascular  and  Interventional  Radiology  [17].
ajor  complications  included  sepsis  or  post-therapeutic
holangitis,  haemorrhages  requiring  a  blood  transfusion,
bscess,  peritonitis,  cholecystitis,  pancreatitis,  pleuropneu-
onia  and  death.  All  other  complications  were  considered
o  be  minor,  including  minimal  haemorrhages,  biliovenous
stula,  subcapsular  biloma,  stent  migrations,  etc.  These
inor  complications  did  not  involve  prolonged  hospitali-
ation.  Cholangitis  was  deﬁned  by  fever  exceeding  38 ◦C
ssociated  with  abdominal  pain  without  any  other  identi-
able  seat  of  infection.
tatistical analysis
he  data  to  calculate  of  the  rate  of  success  of  the  technique,
he  clinical  success  and  the  complications  was  registered
y  computer.  These  rates  were  expressed  as  a  mean  per-
entage.  Two  tests  were  used  to  search  for  the  predictive
actors  of  clinical  success  or  failure  of  the  biliary  drainage.
he  Mann-Whitney-Wilcoxon  test  was  used  during  the  anal-
sis  with  qualitative  variables  and  Fisher’s  exact  test  during
770  M.  Maillard  et  al.
Figure 3. Biliary drainage of a Bismuth type III hilar cholangiocarcinoma: a: MRI with T2 weighting and 3D reconstruction conﬁrming the
dilation of the intrahepatic bile ducts (arrow); b: thin-needle cholangiography with major dilation of the bile ducts of the right para median
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pector that seems to be excluded from the other sectors; c: crossin
iliary tree; d: transitory protection for 48 hours of the incision aft
he  analysis  of  the  quantitative  variables.  The  data  was  con-
idered  to  be  signiﬁcant  in  case  of  P  ≤  0.05.
esults
he population
he  target  population  consisted  of  42  men  (62%)  and
6  women  (38%),  a  sex  ratio  of  about  1.6/1.  The  mean
ge  of  the  patients  at  the  time  of  the  diagnosis  was  69
ears  (38—96  years).  The  mean  ASA  score  was  2.3.  All
f  the  patients  presented  clinical  jaundice  and  biologi-
al  cholestasis  with  alteration  of  their  general  state  and
eight  loss.  Only  three  patients  received  care  during  an
ngiocholitis.  The  total  pre-surgical  bilirubin  level  oscillated
etween  29  and  927  mol/L  with  a  mean  of  336.4  mol/L
N  <  17  mol/L).
etiology and classiﬁcation of hilar
bstructions according to Bismuthhe  causes  of  hilar  obstruction  were  either  cholangiocarci-
omas  (n  =  40),  or  metastases  (n  =  28).  The  hilar  obstruction
as  type  II  in  15  patients,  type  III  in  25  patients,  including
2  type  IIIa  and  three  IIIb,  and  type  IV  in  28  patients.
t
r
T
cee obstructions with three guides enabling the full drainage of the
cement of endoprostheses by internal-external drains.
uccess of the technique
he  success  rate  for  the  technique  was  98.5%.  The  only
ailure  was  complicated  by  the  death  of  the  patient  fol-
owing  haemorrhagic  shock  before  the  placement  of  the
ndoprostheses.  One  hundred  and  thirty  two  procedures
ere  carried  out  in  the  67  patients,  representing  a  mean
f  two  procedures  per  patient.  One  hundred  and  sixty-one
ndoprostheses  were  placed  with  a  minimum  of  two  and  a
aximum  of  four  prostheses.
linical success
ue  to  the  retrospective  nature  of  our  study,  a full  biolog-
cal  assessment  was  not  available  for  all  of  the  patients  in
ur  population.  Of  the  50  patients,  where  1  week  of  bio-
ogical  monitoring  was  available,  42  presented  at  least  a
0%  reduction  in  the  total  bilirubin,  that  is,  a  clinical  suc-
ess,  of  84%.  The  reduction  in  the  bilirubin  varied  from  34
o  88%  with  a  mean  of  59.5%.  The  assay  of  the  total  biliru-
in  was  available  after  1  month  for  28  of  the  50  previous
atients.  Twenty-six  of  these  patients  presented  a  reduc-
ion  of  over  75%,  that  is,  a  clinical  success  of  93%  with
eductions  between  75%  and  96%  with  a mean  of  85.5%.
ables  1 and  2  present  the  variations  in  the  rate  of  clini-
al  success  according  to  the  aetiology  of  the  tumour  and
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Table  1  Clinical  success  after  1  week  according  to  the  aetiology  of  the  tumour  and  the  Bismuth  classiﬁcation.
Number  of  successes  Number  of  failures  Success  rate
(%)
Aetiology  of  the  tumour  (n  =  50)
CCK  (n  =  31)  26  5  84
Metastasis  (n  =  19)  16  3  84
Bismuth  classiﬁcation  (n  =  50)
II  (n  =  9) 8 1  89
III  (n  =  20) 16 4 80
IV  (n  =  21) 18 3 86
CCK: cholangiocarcinoma.
Table  2  Clinical  success  after  1  month  according  to  the  aetiology  of  the  tumour  and  the  Bismuth  classiﬁcation.
Number  of  successes  Number  of  failures  Success  rate
(%)
Aetiology  of  the  tumour  (n  =  28)
CCK  (n  =  20)  19  1  95
Metastasis  (n  =  8) 7  1  88
Bismuth  classiﬁcation  (n  =  28)
II  (n  =  5)  4  1  80
III  (n  =  11)  10  1  90
IV  (n  =  12)  12  0  100
CCK: cholangiocarcinoma.
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Ithe  Bismuth  classiﬁcation.  Among  the  eight  clinical  failures
after  1  week,  four  patients  presented  clinical  success  after
1  month.  Among  the  four  remaining  clinical  failures  after  1
month,  two  died,  the  ﬁrst  from  his  cancer  without  an  appar-
ent  link  to  the  drainage,  and  the  second  from  severe  sepsis  1
week  after  the  drainage.  Among  the  two  remaining  patients
in  clinical  failure  after  1  month,  we  note  one  drop-out  and
one  patient  whose  drainage  reduced  the  bilirubin  by  less
than  42%.
Predictive factors of failure
By  analysing  the  different  population  characteristics,  no
predictive  factors  of  clinical  success  or  failure  were
detected.
Complications
The  rate  of  minor  complications  was  25%.  There  were
nine  minor  haemobilias,  ﬁve  bilomas,  one  prosthesis  migra-
tion  treated  by  the  placement  of  another  endoprosthesis,
one  biliocutaneous  leak  and  one  punctured  subcutaneous
haematoma.  The  rate  of  major  complications  was  13%.
Three  patients  died:  one  from  severe  sepsis  probably  of
biliary  origin  and  two  others  from  haemorrhagic  shock
with  haemobilia  and  digestive  haemorrhage.  Two  other
patients  presented  a  haemobilia  requiring  a  transfusion
and  embolisation  for  one  of  them.  One  patient  was
treated  for  pneumopathy.  One  patient  underwent  surgery
t
o
e
sor  cholecystitis  3  weeks  after  the  placement  of  the  endo-
rostheses.  One  patient  presented  acute  kidney  failure  that
leared  up  under  dialysis  and  ﬁnally,  the  last  patient  bene-
ted  from  percutaneous  drainage  for  a  liver  abscess.
iscussion
iliary  drainage  with  the  placement  of  metallic  endopros-
heses  has  become  a  choice  treatment  for  hilar  tumoral
bstructions  [7].  In  fact,  due  to  the  local  aggressiveness  of
he  tumour,  these  patients  most  often  are  not  able  to  beneﬁt
rom  a  curative  treatment  [18]. The  technique  of  drainage
ith  only  one  endoprosthesis  in  sub-hilar  tumours  or  Bis-
uth  type  I  hilar  tumour  is  acknowledged.  Bismuth  type  II,
II  and  IV  hilar  tumours  raise  more  questions  due  to  its  exten-
ion  along  the  bile  ducts.  In  these  cases,  biliary  drainage  of
ne  sector,  one  lobe  or  the  entire  liver  remains  controver-
ial.  Our  study  tried  to  specify  the  success  of  the  technique,
he  clinical  success  and  describe  the  complications  after  1
onth  of  extensive  biliary  drainage  with  the  placement  of
everal  endoprostheses  in  Bismuth  type  II,  III  and  IV  complex
ilar  tumours.
In  our  series,  we  isolated  and  privileged  Bismuth  type
I,  III  and  IV  complex  hilar  tumours  to  discuss  the  value  of
he  placement  of  several  endoprostheses.  The  populations
f  the  other  studies  published  appear  much  more  het-
rogeneous  [11,12,15,19—22].  Endoscopic  or  percutaneous
tudies  most  often  do  not  distinguish  between  patients
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resenting  obstructions  due  to  Bismuth  type  II,  III  and  IV
omplex  hilar  obstruction  and  Bismuth  type  I  hilar  and
ub-hilar  obstruction  [20—22]. As  far  as  we  are  aware,
he  literature  on  percutaneous  drainage  consists  of  a  sin-
le  recent  study  (2003)  where  the  population  is  close  to
urs  [11]. This  publication  is  based  on  a  population  of  117
atients  with  a  complex  hilar  tumour,  including  61  that
equired  bilateral  biliary  drainage.  The  other  recent  studies
n  percutaneous  biliary  drainage  with  the  placement  of  sev-
ral  endoprostheses  in  hilar  tumours  only  include  23  patients
or  another  Inal  study,  20  patients  for  Pappas,  19  patients
or  D’alincourt  and  six  patients  for  Brountzos  [12,20—22].  In
ddition,  as  opposed  to  these  studies,  our  series  presents
 high  percentage  (78%)  of  Bismuth  type  III  and  IV  hilar
umours  that  are,  by  deﬁnition,  the  most  difﬁcult  lesions  to
rain.  This  percentage  is  66  in  the  2003  Inal  study  [20]. The
eterogeneity  is  the  same  in  the  endoscopic  drainage  series.
n  the  studies  by  De  Palma  and  Chang,  54  and  29  patients
resenting  a  Bismuth  type  II  or  III  hilar  tumour  beneﬁted
rom  the  placement  of  two  endoprostheses  [15,19].  Patients
resenting  a  Bismuth  type  IV  tumour  were  not  treated  in
hese  two  studies.  The  other  recent  studies  include  23  and
0  patients  with  Bismuth  type  II,  III  and  IV  obstacles  [16,23].
inally,  one  study  on  85  patients  presenting  Bismuth  type  III
nd  IV  hilar  tumour  compared  endoscopic  and  percutaneous
rainage  [24]. Surprisingly,  the  drainage  technique  and  the
umber  of  endoprostheses  placed  are  not  indicated  in  this
tudy.  Therefore,  our  study,  compared  with  other  recent
tudies,  presents  a  homogenous  and  large  target  popula-
ion.  It  is  of  further  value  since  it  speciﬁcally  studies  the
rainage  with  the  placement  of  several  endoprostheses  in
ismuth  type  II,  III  and  IV  tumours.  In  fact,  in  addition  to
 heterogeneous  population,  the  other  studies  mentioned
bove  also  present  an  imprecise  drainage  strategy  concern-
ng  the  number  of  endoprostheses  chosen  or  placed.  These
actors  account  for  the  difﬁculty  comparing  the  results  of
ur  study  with  that  of  the  existing  literature.
The  rate  of  success  of  the  technique  is  high  in  our  series
98.5%).  This  high  rate  of  success  is  mainly  due  to  the  expe-
ience  of  the  different  operators  and  appears  similar  to  the
ther  recent  percutaneous  studies  since  all  of  these  stud-
es  claim  a  100%  success  rate  [11,12,20—22]. This  high  rate
hould  be  considered  since  biliary  drainage  may  involve  sev-
ral  procedures,  as  is  the  case  for  78%  of  our  patients.  In
act,  the  ﬁrst  procedure  does  not  always  cross  all  obstruc-
ions  due  to  the  major  dilation  of  the  intrahepatic  bile  ducts,
ssociated  with  the  hard  and  ﬁbrous  nature  of  the  obstruc-
ion.  A  second  procedure  is  then  required.  Eighty-three
ercent  of  our  patients  only  required  one  or  two  procedures
o  totalise  the  drainage.  The  recent  endoscopic  series  also
ad  high  rates  of  success  of  the  technique,  ranging  from  73
o  100%.  These  results  are  often  not  as  good  as  those  of  the
ercutaneous  series,  in  particular  for  the  bilateral  drainage
ith  a  rate  of  76.9%  for  De  Palma  and  90%  for  Naitoh  in  78
atients  and  29  patients  respectively.  These  rates  drop  to
6%  and  87%  if  only  Bismuth  type  II,  III  and  IV  cholangiocar-
inoma  are  taken  into  account  [15,16].  Rerknimitr  presents
 100%  rate  of  success  with  the  bilateral  drainage  of  complex
ilar  tumours  although  on  a  small  population  of  30  patients
23].  The  superiority  of  the  percutaneous  series  in  biliary
rainage  with  the  placement  of  several  endoprostheses  is
argely  due  to  the  easier  accessibility  of  the  intrahepatic  bile
i
t
T
tM.  Maillard  et  al.
ucts  by  transhepatic  approach  than  by  endoscopy.  During
ndoscopic  biliary  drainage,  the  endoprostheses  are  placed
nder  scopic  control  after  retrograde  cholangiography.  The
holangiogramme  obtained  is  sometimes  incomplete  since
he  contrast  product  is  stopped  by  the  complete  obstruc-
ion.  The  placement  of  the  endoprostheses  then  becomes
ore  random  as  concerns  the  choice  of  biliary  sectors  to  ﬁt.
n  case  of  radiological  drainage,  the  percutaneous  approach
nder  sonographic  control  of  the  bile  ducts  associated  with
he  analysis  of  the  MRI  data  and  the  CT  imaging  enable  the
ost  complete  direct  cholangiography  possible.  The  plan-
ing  of  the  procedure  thereby  seems  to  be  better.
Although  the  biological  data  is  not  available  on  the  68
atients  in  our  series,  the  rate  of  clinical  success  after  1
eek  and  1  month  are  high  (84%  and  93%  respectively).
hese  rates  are  similar,  whether  they  involve  primary  or
econdary  tumours  and  also  whatever  the  Bismuth  classi-
cation.  These  results  are  not  found  in  the  other  series  of
ercutaneous  drainage.  In  these  series,  the  rate  of  clini-
al  success  deteriorates  for  Bismuth  type  III  and  IV  tumour.
herefore,  in  the  2003  study  by  Inal  et  al.,  the  success  rate
ecreases  from  100%  in  case  of  Bismuth  type  I or  II  tumour,
o  95%  in  case  of  Bismuth  type  III  tumour  and  66%  in  case  of
ismuth  type  IV  tumour  [11]. In  the  other  2003  Inal  study,  the
nding  is  similar  with  a  clinical  rate  of  success  of  90%  when
ncluding  hilar  and  sub-hilar  tumours,  82%  in  case  of  Bismuth
ype  II,  III  and  IV  tumours  and  71%  in  case  of  Bismuth  type
II  and  IV  tumours  [20]. The  rate  of  clinical  success  in  recent
ndoscopic  series  is  not  as  good,  in  particular  for  Bismuth
II  and  IV  hilar  tumours  with  a  rate  ranging  from  73  to  100%
15,16,19,23].  The  rate  of  success  in  series  with  selection
riteria  closest  to  ours  is  73%  and  77.3%.  Paik  has  a  clini-
al  rate  of  success  of  77.3%  in  a  population  of  44  patients
resenting  Bismuth  type  III  or  IV  hilar  tumour  and  De  Palma
as  a  rate  of  success  of  73%  for  the  bilateral  drainage  of
8  hilar  tumours  including  54  Bismuth  type  II  and  III  hilar
umours  and  24  Bismuth  type  I tumour  [15,24].  This  differ-
nce  in  the  clinical  rate  of  success  between  the  series  of
ercutaneous  and  endoscopic  biliary  drainage,  like  the  rate
f  success  of  the  technique,  is  due  to  the  easier  access  to  the
ntrahepatic  bile  ducts  by  percutaneous  route.  Therefore,  in
he  percutaneous  biliary  drainages,  in  case  of  Bismuth  type
II  or  IV  hilar  tumours,  it  is  possible  to  drain  three  biliary  sec-
ors  in  order  to  obtain  the  most  complete  biliary  drainage
ossible.  This  was  the  case  for  19  of  our  patients.  With  endo-
copic  drainage,  it  is  only  rarely  possible,  with  experienced
perators,  to  drain  more  than  two  sectors  [25].
Cholangitis,  haemobilia  and  biliary  leaks  are  early
omplications  most  often  encountered  with  percutaneous
iliary  drainage  [20]. The  overall  rate  of  complications  in  our
eries  is  38%  with  25%  minor  complications  and  13%  major
omplications.  This  rate  is  similar  that  of  the  endoscopic
r  percutaneous  series  treating  the  same  type  of  popula-
ion.  In  fact,  the  studies  by  Inal,  Paik  and  De  Palma  indicate
n  overall  rate  of  complications  of  29%,  31.7%,  29.5%  and
6.9%  [11,15,24]. Our  complications  are  closely  related  to
he  number  of  procedures,  the  number  of  approaches  and
he  Bismuth  classiﬁcation.  The  overall  rate  of  complications
ncreases  with  an  increase  in  the  number  of  procedures,
he  number  of  approaches  and  the  Bismuth  classiﬁcation.
he  ASA  score  does  not  inﬂuence,  as  could  be  expected,
he  rate  of  complications.  Nevertheless,  these  results  are
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predictable  since  the  number  of  approaches  and  the  number
of  procedures  attest  to  the  difﬁculty  in  drainage.  Drainages
with  the  lowest  number  of  procedures  and  approaches
limit  the  number  of  complications.  Moreover,  Inal  already
demonstrated  that,  if  possible,  it  is  preferable  to  place  the
endoprostheses  directly  without  preliminary  biliary  drainage
in  order  to  minimise  complications  [20]. Eighty-four  percent
of  our  target  population  beneﬁted  from  one  or  two  pro-
cedures  for  the  biliary  drainage,  thereby  limiting  the  risks
related  to  surgical  procedures.
This  study  presents  several  biases  and  imperfections.
First,  due  to  the  retrospective  nature  of  the  study,  biological
data  is  not  available  on  all  of  the  patients.  Some  data  has
been  lost  or  never  recorded.  Some  patients  have  dropped-
out  and  we  do  not  know  whether  the  drainage  was  a  clinical
success  or  failure.  Since  the  radiology  department  at  Hôpi-
tal  l’Archet  is  a  regional  reference  centre  for  percutaneous
biliary  drainage,  some  of  the  patients  treated  only  were  hos-
pitalised  for  48  h  before  being  sent  back  to  their  original
department.  After  48  h,  these  patients  presented  a  decrease
in  the  total  bilirubin.  Nevertheless,  it  remained  under  30%.
Second,  this  series  on  percutaneous  biliary  drainage  with
the  placement  of  several  endoprostheses  should  have  been
compared  with  a  series  of  percutaneous  drainages  with  the
placement  of  a  single  endoprosthesis  in  a  prospective  con-
trol  study.  However,  this  type  of  study  is  difﬁcult  to  carry
out  due  to  the  relative  rarity  of  malignant  hilar  tumours.
Third,  in  this  study  we  did  not  try  to  detail  the  medium  and
long-term  permeability  of  the  prostheses.  It  is  therefore  not
possible  to  specify  whether  or  not  multiple  stenting  is  a  fac-
tor  that  increases  or  decreases  the  long-term  permeability
of  endoprostheses.  Nevertheless,  we  know  that  the  mean
duration  of  permeability  of  metal  stents  is  approximately
the  same  as  the  mean  life  expectancy  of  patients  presenting
malignant  bile  duct  obstruction  [9].  Another  bias  is  due  to
the  chose  of  biliary  sectors  to  drain.  The  therapeutic  strat-
egy  in  our  study  was  to  avoid  draining  atrophied  hepatic
sectors  or  those  presenting  major  invasion  by  the  tumour.
This  choice  was  subjective  and  depended  on  the  operators
and  was  not  based  on  an  objective  analysis,  in  particular  by
hepatic  volumetry.
Conclusion
With  a  rate  of  success  of  the  technique  of  almost  100%  and  a
clinical  success  rate  of  about  90%,  our  series  on  multiple  per-
cutaneous  biliary  drainage  in  complex  hilar  tumours  appear
more  effective  than  the  series  of  endoscopic  or  percuta-
neous  drainage  recently  published  treating  the  same  type  of
population.  As  opposed  to  these  studies,  the  biliary  drainage
of  a  Bismuth  type  IV  hilar  tumour  appears  as  effective  as  that
of  a  Bismuth  type  II  tumour.  The  rate  of  major  complications
of  13%  in  our  series  appears  to  be  fully  acceptable  in  view
of  the  fragility  of  our  population  consisting  of  over  75%  Bis-
muth  type  III  and  IV  tumour  with  a  mean  age  of  69  years  and
a  mean  ASA  score  of  2.3.  Therefore,  we  consider  that  the
most  complete  percutaneous  biliary  drainage  possible  with
the  placement  of  several  endoprostheses  should  be  proposed
in  ﬁrst  intention.  However,  a  randomised  prospective  study
comparing  partial  biliary  drainage  with  total  biliary  drainage
[mours  773
n the  same  type  of  population  seems  to  be  necessary  in
rder  to  back  up  our  results.
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